...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi)
【24h】

Diagnosis of Dementia in the Specialist Setting: A Comparison Between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi)

机译:在专家环境下对痴呆症的诊断:瑞典痴呆症登记处(SveDem)和赫罗纳痴呆症登记处(ReDeGi)的比较

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study was to compare the frequency of dementia diagnoses from two dementia registries in Europe. Patients registered between 2007 and 2013 in the Swedish Dementia Registry (SveDem; Sweden) and in the Registry of Dementias of Girona (ReDeGi; North-East of Spain) were selected. We compared sociodemographic data, Mini-Mental State Examination (MMSE) scores, dementia subtype, and medication consumption of 22,384 cases from SveDem and 5,032 cases from ReDeGi. The average age (78.1 years SveDem versus 79.7 years ReDeGi) and the gender (female 58.2% SveDem versus 61.5% ReDeGi) did not greatly differ. MMSE score at diagnosis was higher for SveDem cases (22.1 versus 17.8). Alzheimer's disease (AD) accounted for the main dementia subtype (36.6% SveDem versus 55.6% ReDeGi). The proportion of vascular dementia (VaD) and mixed dementia was higher in SveDem (18.8% versus 6.4% and 24.9 versus 13.4%), with an odds ratio (OR) and 95% confidence interval (CI) for SveDem relative to the ReDeGi of 3.41 (3.03-3.84) for VaD, and 2.15 (1.97-2.35) for mixed dementia. This was at the expense of a lower frequency of AD in SveDem (OR 0.41; 95% CI 0.39-0.44). Other dementia diagnoses such as frontotemporal dementia or dementia with Lewy bodies did not significantly differ between registries (2.3% versus 2.9%; 1.9 versus 3.1%). Large differences in medication consumption at the time of dementia diagnosis were detected (4.7 treatments SveDem versus 6.8 ReDeGi). Northern and southern European dementia cohorts differ in demographic characteristics, MMSE score at diagnosis, and drug treatment profile.
机译:这项研究的目的是比较欧洲两个痴呆症登记处对痴呆症的诊断频率。选择了2007年至2013年之间在瑞典痴呆症注册表(SveDem;瑞典)和赫罗纳痴呆症注册表(ReDeGi;西班牙东北部)中注册的患者。我们比较了来自SveDem的22,384例病例和ReDeGi的5,032例病例的社会人口统计学数据,迷你精神状态检查(MMSE)得分,痴呆亚型和药物消耗。平均年龄(78.1岁SveDem对79.7岁ReDeGi)和性别(女性58.2%SveDem对61.5%ReDeGi)没有太大差异。 SveDem病例在诊断时的MMSE评分较高(22.1对17.8)。阿尔茨海默氏病(AD)是主要的痴呆亚型(SveDem为36.6%,ReDeGi为55.6%)。 SveDem中血管性痴呆(VaD)和混合性痴呆的比例更高(18.8%比6.4%和24.9比13.4%),相对于ReDeGi,SveDem的优势比(OR)和95%置信区间(CI) VaD为3.41(3.03-3.84),混合性痴呆为2.15(1.97-2.35)。这是以降低SveDem中AD的频率为代价的(OR 0.41; 95%CI 0.39-0.44)。其他痴呆症的诊断,如额颞叶痴呆或路易体痴呆在两个注册表之间没有显着差异(2.3%对2.9%; 1.9对3.1%)。在痴呆症诊断时发现药物消耗存在很大差异(SveDem的4.7种治疗与ReDeGi的6.8种治疗)。北欧和南部欧洲痴呆人群在人口统计学特征,诊断时的MMSE评分和药物治疗情况方面有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号